Monographie - Bortezomib

Ultimo aggiornamento :
19/11/2024

Bortezomib

Struttura chimica

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bemoncaz	Messico
Bicavan	Chile
Biemib	Turchia
Bomib	Messico
Borater	Argentina
Borcade	Turchia
Bormib	Argentina
Bortezomib	nuova Zelanda
Bortezun	Ecuador
Bortrac	Ecuador, Perù
Bortzo	Perù
Botemib	Chile, Ecuador, Perù
Bozix	Chile, Perù
Bozob	Argentina, Ecuador, Perù
Bromadene	Argentina
Egybort	India
Elomaziv	Messico
Gysatri	Argentina
Miasoma	Argentina
Mibor	Perù
Multizom	Argentina
Rebtik	Chile
Velcade	Arabia Saudita, Argentina, Australia, Austria, Belgio, Canada, Chile, Colombia, Danimarca, Egitto, Emirati Arabi Uniti, Finlandia, Francia, Germania, Giappone, Gran Bretagna, Grecia, Irlanda, Islanda, Italia, Lussemburgo, Malaysia, Messico, Norvegia, nuova Zelanda, Paesi Bassi, Polonia, Portogallo, Romania, Spagna, Stati Uniti d’America, Svezia, Svizzera, Turchia, Ungheria, Venezuela
Velcord	Perù
Vortemyel	Romania
Zefra	Argentina
Zegomib	Romania
Zuricade	Messico

Bibliografia : Bortezomib

	tipo	pubblicazione
1911	Laboratorio	Bortezomib (Velcade®) - Summary of Product Characteristics Janssen-Cilag Ltd 2016
2010	Rivista	André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE. Stability of bortezomib 1 mg/ml solution in plastic syringe and glass vial. Ann Pharmacotherapy 2005 ; 39: 1462-1466.
2011	Rivista	Friess D, Nguyen HC, Lipp HP. HPLC-stabilitätuntersuchungen zu rekonstituierten Bortezomib-Lösungen. Krankenhauspharmazie 2005 ; 26, 6: 206-210.
2232	Rivista	Walker SE, Milliken D, Law S. Stability of Bortezomib Reconstituted with 0.9% Sodium Chloride at 4°C and Room Temperature (23°C) Can J Hosp Pharm 2008 ; 61, 1: 14-20.
3190	Rivista	Bolognese A, Esposito A, Manfra M, Catalano L, Petruzziello F, Martorelli MC, Pagliuca R, Mazzarelli V, Ottiero M, Scalfaro M, An NMR Study of the Bortezomib Degradation under Clinical Use Conditions. Advance in Haematology 2009 Article ID 704928, 5 page
3240	poster	Perissutti M, Vigneron J, Zenier H, May I, Demoré B. Etude de la stabilité d'une solution de bortézomib à 1 mg/mL conditionnée en seringue de polypropylène. Congrès SFPO 2011
3337	Rivista	Carati D, Masini C, Minguzzi M, Petocchi B, Romanazzi C, Rondoni C, Sangiorgi E, Sferra S, Simonetta S, Stancari A, Locchi F, Z Stability of bortezomib reconstituted under clinical use conditions in original vials and polypropylene syringes at 4 °C and room temperature. EJHP 2012 ; 19: 428-431.
3349	Rivista	Bosch-Ojeda C, Sanchez-Rojas M.F, Espinosa-Bosch M. Chemical stability of bortezomib solutions in original manufacturer vials. Int J Pharm Bio Sci 2012 ; 2, 3: 344-350.
3418	Rivista	Berruezo garcia J, Espinosa Bosch M, Sanchez Rojas F, Bosch Ojeda C Chemical stability of bortezomib solutions in original manufacturer vial at room temperature and in syringe at 4°C. Int J Pharm Bio Sci 2013 ; 3, 1: 449-458.
3447	poster	Giovanelli M, Vigneron J, May I, Nicolas A. Etude de la stabilité d’une solution de bortézomib à 2,5 mg/mL par chromatographie liquide à haute performance couplée à un détecteur à barrettes de diodes et à un détecteur évaporatif à diffusion de lumière. SFPO Congress, Mandelieu, France 2013
3537	Rivista	Lipp HP, Gfrörer W, Riedmüller S. Bortezomib zur subkutanen Applikation. Krankenhauspharmazie 2013 ; 34,11: 500-505.
3688	Rivista	Walker S.E, Charbonneau L.F, Law S. Stability of bortezomib 2.5 mg/mL in vials and syringes stored at 4°C and room temperature (23°C). Can J Hosp Pharm 2014 ; 67, 2: 102-107
4137	Rivista	Patel T, Sewell G. Short Report : Extended Stability Studies on Bortezomib Injection and Infusions of Cisplatin and Pemetrexed (all Accord Healthcare). Newsletter Stabilis 2018 41;2-6
4485	Rivista	Law S, Charbonneau L, Iazetta J, Perks W, Ma N, Walker S.E. Stability of Generic Formulations of Bortezomib 1.0 and 2.5 mg/mL in Vials and Syringes Stored 4°C and Room Temperature (23°C) Can J Hosp Pharm 2021 ;74;1:57-69

Mentions Légales